Clinical Trials
4 trialsNCT07169708 2026-05-20
A Retrospective Observational Study of Nivolumab in Combination With Chemotherapy as Neoadjuvant Therapy for Resectable NSCLC Patients: Real-World Experience in Taiwan (NEOREAL)
Ono Pharmaceutical Co., Ltd.
Recruiting
NCT06680050 2025-12-18
AUSTRAL
Mario Negri Institute for Pharmacological Research
Phase 2 Recruiting
NCT07188480 2025-09-23
The Role of DNA and RNA in NGS Analyses for Advaced Stage NSCLC Patients
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Phase NA Recruiting
NCT07087223 2025-07-25
Phase Ib/II Study of Vebreltinib With Furmonertinib in NSCLC Patients With c-Met Amplification After EGFR-TKI Failure
Peking University Cancer Hospital & Institute
Phase 1/2 Recruiting